Saturday 17 October 2026 Export RYTM’s income statement to Excel — free account

Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $189.8 million, up 45.8% from fiscal 2024. In the quarter to June 2026, revenue grew 46.9%, EPS grew 2.67% and free cash flow grew 60.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

86.17 1.80 −2.05%

Follow RYTM

Alert me

Market cap: $6.1B
P/E: 0.0×
Fwd P/E: −26.9×
Dividend yield: —
F-score: 6/9
Altman Z: 15.89
Beneish M: −2.93
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	6	5	4
ROE Full definition →		(247.13%)	(251.14%)	(293.04%)	(461.65%)
ROA Full definition →		(45.44%)	(46.29%)	(50.14%)	(51.91%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(50.60%)	(55.77%)	(63.37%)	(69.36%)
Average Days of Receivables Full definition →		69.16	50.17	57.47	61.47
Free Cash Flow per Share Full definition →		(2.26)	(2.42)	(1.76)	(1.54)
Free Cash Flow Full definition →		(149.63)	(157.13)	(119.51)	(105.35)
Capital Expenditures Full definition →		(40.50)	(41.45)	—	—
Other line items
Cash ROIC Full definition →		(21.02%)	(23.84%)	(20.67%)	(19.22%)
Accounts Receivable Turnover Full definition →		6.66	8.51	8.35	7.21
Accounts Payable Turnover Full definition →		2.00	1.48	1.90	1.64
Inventory Turnover Full definition →		1.03	0.88	0.96	1.07
Average Days of Payables Full definition →		269.29	261.17	195.17	223.59
Days of Inventory on Hand Full definition →		436.73	482.24	454.66	422.10
Tax Rate Full definition →		0.00	0.00	0.00	0.01
Research and Development Expense of Revenue Full definition →		95.49%	88.19%	79.24%	72.20%
Selling, General and Administrative Expense of Revenue Full definition →		100.72%	102.73%	101.05%	100.43%
Share Based Compensation of Revenue Full definition →		33.33%	35.21%	35.48%	36.36%
Interest Coverage Full definition →		(8.48)	(9.33)	(9.99)	(10.86)
Operating CF/Net income Full definition →		0.55	0.57	0.58	0.50
Depreciation/Fixed assets Full definition →		6.11	1.21	1.13	10.48
Capex/Depreciation Full definition →		(27.95)	(30.98)	0.00	0.00
Revenue per Share Full definition →		2.63	2.92	3.19	3.50
Operating CF per Share Full definition →		(1.65)	(1.78)	(1.76)	(1.54)
Capex per Share Full definition →		(0.61)	(0.64)	0.00	0.00
Capex to Sales Full definition →		0.23	0.22	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly